Literature DB >> 28549996

Effect of PR interval prolongation on long-term outcomes in patients with left bundle branch block vs non-left bundle branch block morphologies undergoing cardiac resynchronization therapy.

John Rickard1, Mohammad Karim2, Bryan Baranowski2, Daniel Cantillon2, David Spragg3, W H Wilson Tang2, Mark Niebauer2, Richard Grimm2, Kevin Trulock2, Bruce Wilkoff2, Niraj Varma2.   

Abstract

BACKGROUND: Although the influence of QRS duration (QRSd) and/or bundle branch block morphology on outcomes of cardiac resynchronization therapy (CRT) have been well studied, the effect of PR interval remains uncertain.
OBJECTIVE: The purpose of this study was to evaluate the impact of PR prolongation (PRp) before CRT on long-term outcomes, specifically taking into account bundle branch block morphology and QRSd.
METHODS: We extracted clinical data on consecutive patients undergoing CRT. Multivariate models were constructed to analyze the effect of PRp (≥200 ms) on the combined endpoint of death, heart transplant, or left ventricular assist device. Kaplan-Meier curves were constructed stratifying patients based on bundle branch block and QRSd (dichotomized by 150 ms).
RESULTS: Of the 472 patients who met inclusion criteria, 197 (41.7%) had PR interval ≥200 ms. During follow-up (mean 5.1 ± 2.6 years) there were 214 endpoints, of which 109 (23.1%) occurred in patients with PRp. In multivariate analysis, PRp was independently associated with worsened outcomes (hazard ratio 1.34, 95% confidence interval 1.01-1.77, P = .04). When stratified by bundle branch block morphology, PRp was significantly associated with worsened outcomes (log-rank P <.001) in patients with LBBB but not in those with non-LBBB (log-rank P = .55). Among patients with LBBB, stratified by QRSd, patients without PRp had improved outcomes compared to those with PRp independent of QRSd (log-rank P <.001).
CONCLUSION: PRp is an independent predictor of impaired long-term outcome after CRT among patients with LBBB but not in non-LBBB patients. Notably, among LBBB patients, PRp is a more important predictor than QRSd in assessing long-term outcomes.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiac resynchronization therapy; Left bundle branch block; Non–left bundle branch block; PR interval; Survival

Mesh:

Year:  2017        PMID: 28549996     DOI: 10.1016/j.hrthm.2017.05.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  6 in total

1.  Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.

Authors:  Albert K Feeny; John Rickard; Divyang Patel; Saleem Toro; Kevin M Trulock; Carolyn J Park; Michael A LaBarbera; Niraj Varma; Mark J Niebauer; Sunil Sinha; Eiran Z Gorodeski; Richard A Grimm; Xinge Ji; John Barnard; Anant Madabhushi; David D Spragg; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-06-20

2.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

Review 3.  Advances in Cardiac Resynchronization Therapy.

Authors:  Asif Jafferani; Miguel A Leal
Journal:  J Innov Card Rhythm Manag       Date:  2019-06-15

4.  Baseline Prolonged PR Interval and Outcome of Cardiac Resynchronization Therapy: A Systematic Review and Meta-analysis.

Authors:  Pattara Rattanawong; Narut Prasitlumkum; Tanawan Riangwiwat; Napatt Kanjanahattakij; Wasawat Vutthikraivit; Pakawat Chongsathidkiet; Ross J Simpson
Journal:  Arq Bras Cardiol       Date:  2018-10-11       Impact factor: 2.000

5.  Heart rate-adjusted PR as a prognostic marker of long-term ventricular arrhythmias and cardiac death in ICD/CRT-D recipients.

Authors:  Yu-Qiu Li; Shuang Zhao; Ke-Ping Chen; Yang-Gang Su; Wei Hua; Si-Lin Chen; Zhao-Guang Liang; Wei Xu; Yan Dai; Xiao-Han Fan; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

6.  Physiologic heart rate dependency of the PQ interval and its sex differences.

Authors:  Ondřej Toman; Katerina Hnatkova; Peter Smetana; Katharina M Huster; Martina Šišáková; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.